Boston Scientific announces enrollment in MAPS clinical trial

Boston Scientific Corporation has announced that enrollment has begun in its MAPS clinical trial.

The MAPS trial (Matrix And Platinum Science) is designed to identify and investigate clinically relevant endpoints for evaluating the efficacy and durability of endovascular treatment of brain aneurysms. Patients will be randomized to receive either Matrix2(R) Detachable Coils or GDC(R) Detachable Coils. Boston Scientific manufactures GDC coils, the first bare-platinum detachable coil cleared for aneurysm treatment, as well as Matrix2 coils, which are covered with a polyglycolic- polylactic acid (PGLA) bio-polymer shown to improve treatment durability in preclinical studies.

The trial's primary endpoint is target aneurysm recurrence (TAR), which is a composite endpoint comprised of target aneurysm reintervention, target aneurysm rupture or re-rupture or death. The first patient was enrolled and treated on March 29 at the Healtheast Neurovascular Institute, St. Joseph's Hospital in St. Paul, MN by Michael Madison, M.D., and James Goddard M.D., who will be joined in the trial by partners Jeff Lassig, M.D., and Mark Myers, M.D. The MAPS trial is a prospective, multi-center study that is designed to randomize approximately 630 patients at 50 global centers for treatment of brain aneurysms.

"It is gratifying to achieve this milestone of first patient enrollment," said Cameron McDougall, M.D., Chief, Endovascular Neurosurgery, Barrow Neurological Institute, and Co-Principal Investigator of the MAPS Trial. "Not only is this trial important in its own right, but it further demonstrates that multidisciplinary aneurysm trials can and will help define the future of aneurysm treatment."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Ultra-processed foods affect sperm quality and metabolism even without extra calories